Divis Laboratories

BSE : 532488 | NSE : DIVISLAB

Industry : Pharma Drugs | ISIN : INE361B01024 | FreeFloat : 50.00% | FnO : Yes | LotSize : 100


Intellectual Capital (IC)47,772.30
Net Worth (NW)11,728.18
Intrinsic Worth (IW)59,500.48
Market Cap (MC)116,860.60
Economic Value Added522.22
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)80.29%
IC Gross Margin (EBITDA/IC)9.38%
IC Net Margin (NPT/IC)6.93%
Knowledge Turnover (Sales/IC)0.20
Market to Intrinsic Value (MC/IW)1.96

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 2,241.34Rs. 4,402.05
26 May 2022 ---- Rs. 3,448.70
-70.65     -2.05%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 4,020.09SellAvoid
KB > 50% : Yes50 DMA : Rs. 4,355.07
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
1162.88
1193.20
387.14
343.31
373.31
272.44
272.44
Sep-19
C
1445.57
1492.60
490.56
444.63
487.87
356.78
356.78
Dec-19
C
1396.26
1437.93
493.90
447.20
487.32
359.09
359.09
Mar-20
C
1389.71
1466.44
444.45
394.67
470.96
388.23
388.23
Jun-20
C
1730.47
1747.80
700.08
643.88
660.98
492.06
492.06
Sep-20
C
1749.30
1762.94
754.78
693.65
693.49
519.59
521.35
Dec-20
C
1701.44
1720.76
710.53
642.35
642.08
470.62
471.20
Mar-21
C
1788.19
1811.71
739.78
669.70
669.49
502.02
499.63
Jun-21
C
1960.64
1996.61
888.02
814.76
814.48
557.11
558.84
Sep-21
C
1967.86
2006.62
837.18
759.83
759.62
606.46
606.60
Dec-21
C
2493.24
2509.86
1113.80
1033.89
1033.66
902.24
902.87
Mar-22
C
2518.44
2570.83
1156.81
1075.82
1075.74
894.64
894.02
* C - Consolidated, S - Standalone